U.S. Stem Cell, Inc. (USRM)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Aug 14, 2025
U.S. Stem Cell Market Cap
U.S. Stem Cell has a market cap or net worth of $662.00 as of August 22, 2025. Its market cap has decreased by -99.98% in one year.
Market Cap
662.00
Enterprise Value
n/a
Revenue
82.05K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 19, 2008, U.S. Stem Cell's market cap has decreased from 66.74M to 662.00, a decrease of -100.00%. That is a compound annual growth rate of -48.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 662.00 | -99.00% |
| Dec 31, 2024 | 66.15K | 9,892.60% |
| Dec 26, 2023 | 662.00 | -99.98% |
| Dec 30, 2022 | 3.05M | 0.79% |
| Dec 31, 2021 | 3.02M | -43.15% |
| Dec 31, 2020 | 5.31M | 263.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 832.17M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| CytoDyn | 372.33M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |